Losartan is not effective in reducing COVID-19 lung injuries, researchers find - Science Daily

Research found that a common blood pressure medication -- losartan -- is not effective in reducing lung injury in patients with COVID-19.

A study published in JAMA Network Open, from the University of Minnesota, found that a common blood pressure medication -- losartan -- is not effective in reducing lung injury in patients with COVID-… [+1946 chars]

full article...